Alan R. Batkin is Director at CANTEL MEDICAL CORP (CMN). They have made 11 open-market trades across 6 companies since 2006, most recently 2022-06-15.
CIK 0001209120
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
5 open-market purchases totalling $458K since 2008, against 6 sales. Across 5 scored buys the stock is down 0.4% at ninety days, and 2.5 points behind the S&P over the same stretch.
5 scored purchases · one row per filing · discretionary only
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 40% | 20% | 40% |
| Avg Move | -3.6% | -1.5% | -0.4% |
| Alpha | -1.2% | -1.3% | -2.5% |
| Scored | 5 | 5 | 5 |
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| CLI | BUY | 2019-06-19 | 2019-06-21 | $23.95 | $48K | -2.6% | -5.5% | -11.3% |
| PEGI | BUY | 2018-03-07 | 2018-03-08 | $17.19 | $172K | +2.6% | -0.8% | +1.9% |
| PEGI | BUY | 2016-11-21 | 2016-11-21 | $19.02 | $95K | +1.3% | +0.4% | +9.2% |
| PEGI | BUY | 2015-08-14 | 2015-08-17 | $23.15 | $116K | -12.4% | -0.6% | -0.6% |
| OSG | SELL | 2010-06-16 | 2010-06-16 | $42.41 | $42K | -11.6% | -2.0% | -2.0% |
| CMN | SELL | 2009-01-07 | 2009-01-09 | $14.38 | $173K | -7.1% | -3.4% | -3.4% |
| CMN | SELL | 2009-01-06 | 2009-01-06 | $14.68 | $73K | -7.1% | -3.4% | -3.4% |
| OMC | BUY | 2008-10-27 | 2008-10-29 | $27.40 | $27K | -6.9% | -1.1% | -1.1% |
| DO | SELL | 2006-09-27 | 2006-09-29 | $72.21 | $36K | -16.0% | +4.8% | +4.8% |
| DO | SELL | 2006-03-29 | 2006-06-28 | $78.33 | $39K | -16.0% | +4.8% | +4.8% |
| DO | SELL | 2006-03-29 | 2006-03-30 | $87.89 | $44K | -16.0% | +4.8% | +4.8% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.
| OSG |
| 25,551 |
| $119K |
| DO | 500 | $7K |
| EG8R*NSC | 19,877 | — |
| Total | $19.6M |
Shares reported on the most recent Form 4, priced at the 2022-06-17 close. 1 holding could not be priced and is excluded from the total.